ACB
ASEI

Aristotle Capital Boston’s AMER SCIENCE & ENGR INC. ASEI Stock Holding History

Aristotle Capital Boston’s Portfolio ASEI Stock Details ASEI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-75,669
Closed -$2.83M – 104
2016
Q2 		$2.83M Buy
75,669
+1,641
+2% +$50.6K 0.55% 84
2016
Q1 		$2.05M Buy
74,028
+7,655
+12% +$229K 0.41% 89
2015
Q4 		$2.75M Buy
66,373
+21,960
+49% +$875K 0.56% 84
2015
Q3 		$1.58M Buy
44,413
+1,556
+4% +$63.3K 0.39% 93
2015
Q2 		$1.88M Buy
42,857
+12,119
+39% +$524K 0.43% 93
2015
Q1 		$1.5M Buy
30,738
+11,005
+56% +$555K 0.47% 89
2014
Q4 		$1.02M Buy
+19,733
New +$986K 0.51% 90

Aristotle Capital Boston's ASEI Position: Q3 2016 in Review

Aristotle Capital Boston sold out of AMER SCIENCE & ENGR INC. (ASEI) in Q3 2016, closing a stake of 75,669 shares — an estimated $2.83M sold.

Aristotle Capital Boston first reported a position in ASEI in Q4 2014 and held it in 7 quarters. The position peaked at $2.83M in Q2 2016. 0 funds tracked by Wall St. Rank hold ASEI as of Q3 2016.

  • Aristotle Capital Boston reported no remaining AMER SCIENCE & ENGR INC. position as of Q3 2016 after selling out during the quarter.
  • Aristotle Capital Boston sold 75,669 AMER SCIENCE & ENGR INC. shares in Q3 2016, an estimated $2.83M.
  • Aristotle Capital Boston first reported a position in AMER SCIENCE & ENGR INC. in Q4 2014 and held it in 7 quarters.
  • Aristotle Capital Boston's AMER SCIENCE & ENGR INC. position peaked at $2.83M in Q2 2016.
  • 0 funds tracked by Wall St. Rank held AMER SCIENCE & ENGR INC. as of Q3 2016.

Based on Aristotle Capital Boston's 13F filing for Q3 2016, filed 14 Nov 2016.